New York, NY – Researchers at the Icahn School of Medicine at Mount Sinai have identified a novel mechanism by which the coronavirus responsible for COVID-19 may spread through the lungs, transforming previously resistant cells into infection targets. This discovery offers a clearer understanding of the widespread inflammation and organ damage observed in severe cases and could pave the way for new treatment strategies. The findings were detailed in a study published in Nature Communications.
According to the research, lung cells infected with SARS-CoV-2 release "tiny particles that carry the key proteins the virus uses to enter cells." These particles, when absorbed by other cells, including immune and blood vessel cells, render them susceptible to infection. This process effectively expands the virus's reach within the body, exacerbating the disease's impact.
The mechanism helps to explain why COVID-19 can lead to such extensive inflammation and organ damage. By converting non-susceptible cells into targets, the virus can continuously infect new cell types, contributing to the severe systemic effects seen in many patients. This insight is crucial for understanding the pathology of the disease beyond direct viral replication.
The study highlights the potential for developing new therapeutic interventions that could interrupt this particle-mediated spread. Targeting these tiny particles or the cellular pathways they activate could prevent the virus from turning more cells into infection sites, thereby reducing inflammation and protecting vital organs. Further research is expected to explore these promising avenues.
This research builds upon a growing body of knowledge regarding SARS-CoV-2's complex interactions with host cells, including the role of extracellular vesicles in viral pathogenesis and immunomodulation. Understanding these intricate processes is vital for developing more effective treatments and improving patient outcomes in the ongoing fight against COVID-19.
